SCHEMBL17599499

SCHEMBL17599499

COC(=O)C1=C(c2ccc(NS(=O)(=O)c3c(C)c(C)cc(C)c3C)c3ccccc23)CCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KEAP1 Q14145 5/20 0.48
▸ NFE2L2 Q16236 2/20 0.48
▸ ALDH1A1 P00352 3/20 0.46
▸ MEN1 O00255 3/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ HPGD P15428 2/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ CRHBP P24387 1/20 0.46
▸ CRHR2 Q13324 1/20 0.46
▸ SLC6A3 Q01959 8/20 0.43
▸ SLC6A2 P23975 5/20 0.43
▸ TP53 P04637 2/20 0.42
▸ MAPT P10636 1/20 0.42
▸ SLC6A4 P31645 1/20 0.40
▸ GAA P10253 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599453 0.89 KEAP1 (0.46) KEAP1NFE2L2ALDH1A1MEN1KMT2A
SCHEMBL17599527 0.84 SLC6A3 (0.53) KEAP1NFE2L2ALDH1A1MEN1KMT2A
SCHEMBL17599324 0.76 MEN1 (0.47) KEAP1NFE2L2ALDH1A1MEN1KMT2A
SCHEMBL17599551 0.74 SLC6A2 (0.43) KEAP1NFE2L2ALDH1A1MEN1KMT2A
SCHEMBL17612857 0.72 SLC6A3 (0.51) ALDH1A1KDM4EHPGDHSD17B10SLC6A3
SCHEMBL17599346 0.71 CDC25B (0.45) KEAP1NFE2L2ALDH1A1MEN1KMT2A
SCHEMBL17599329 0.71 KMT2A (0.55) KEAP1NFE2L2ALDH1A1MEN1KMT2A
SCHEMBL17599363 0.71 MEN1 (0.53) KEAP1NFE2L2ALDH1A1MEN1KMT2A
SCHEMBL17599477 0.71 KEAP1 (0.59) KEAP1NFE2L2ALDH1A1MEN1KMT2A
SCHEMBL17599481 0.71 KEAP1 (0.50) KEAP1NFE2L2ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2997966-A1 Naphthyl Sulfonamide Pyrrolidine Derivatives as KEAP-1 Modulators for the Treatment of Diabetes, Obesity, Dyslipidemia and Related Disorders SANOFI (FR) 2016-03-23 — — EP disclosed
Send feedback